• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Whitmore Bradford T bought $28,093,800 worth of shares (6,689,000 units at $4.20) and sold $28,093,800 worth of shares (6,689,000 units at $4.20) (SEC Form 4)

    6/2/25 4:01:15 PM ET
    $SLSN
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $SLSN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    WHITMORE BRADFORD T

    (Last) (First) (Middle)
    5215 OLD ORCHARD ROAD
    SUITE 620

    (Street)
    SKOKIE IL 60077

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    SOLESENCE, INC. [ SLSN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/29/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/29/2025 P 2,500,000 A $4.2 26,184,270 I(1) By Strandler, LLC
    Common Stock 05/29/2025 P 4,189,000 A $4.2 30,373,270 I(1) By Strandler, LLC
    Common Stock 05/29/2025 S 2,500,000 D $4.2 22,858,879 I(2) By Whitmore Holdings, LLC
    Common Stock 05/29/2025 S 4,189,000 D $4.2 18,669,879 I(2) By Whitmore Holdings, LLC
    Common Stock 108,141 D
    Common Stock 675,515 I(3) By Grace Investments, LP
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. As manager of Strandler, LLC, Bradford T. Whitmore is the indirect beneficial owner of these shares.
    2. As manager of Whitmore Holdings, LLC (and trustee of Bradford Whitmore Trust, the sole member of Whitmore Holdings, LLC), Bradford T. Whitmore is the indirect beneficial owner of these shares.
    3. As manager of INV-GP, LLC, which is the General Partner of Grace Investments, LP, Bradford T. Whitmore is the indirect beneficial owner of these shares.
    Bradford T. Whitmore 06/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $SLSN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SLSN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SLSN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Solésence Expands Debt Facilities to Fuel Growth Initiatives

      ROMEOVILLE, Ill., June 02, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it entered into amendments on May 27, 2025 to its existing loan agreements, providing increased borrowing capacity to support the execution of strategic objectives. The new facility expands the Company's three loan agreements to a maximum borrowing capacity from $14.2 million to $23.0 million and extends the maturity date under each respective loan agreement from October 1, 2025 to April 30, 2027. The additional borrowing capacity provides Solésence with significant financial flexibil

      6/2/25 8:00:00 AM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Solésence Reports Record First Quarter 2025 Financial Results

      First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025.    Recent Highlights and Accomplishments Uplisted to Nasdaq under the ticker "SLSN" supporting the Company's increased visibility with the investment communityAchieved record revenue and unit volume shipments in the first quarter 2025 "We kicked off 2025 with record revenue, fueled by strong sales across our suite of consumer products," said Jess Jankowski, President and

      5/5/25 4:01:00 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

      ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2025 after the market close on Monday, May 5, 2025, and host a conference call and webcast on the same date. First Quarter 2025 Conference Call Details Date / Time: Monday, May 5, 2025 - 4:00 p.m. CDT, 5:00 p.m. EDT Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer Webcast Link: https://edge.media-server.com/mmc/p/q53hzimg Dial-In Link: https://register-conf.

      4/28/25 4:01:00 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary

    $SLSN
    SEC Filings

    See more
    • Solesence Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - SOLESENCE, INC. (0000883107) (Filer)

      6/2/25 6:00:36 AM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary
    • SEC Form 10-Q filed by Solesence Inc.

      10-Q - SOLESENCE, INC. (0000883107) (Filer)

      5/13/25 5:29:50 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Solesence Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - SOLESENCE, INC. (0000883107) (Filer)

      5/7/25 4:20:12 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary

    $SLSN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Whitmore Bradford T bought $28,093,800 worth of shares (6,689,000 units at $4.20) and sold $28,093,800 worth of shares (6,689,000 units at $4.20) (SEC Form 4)

      4 - SOLESENCE, INC. (0000883107) (Issuer)

      6/2/25 4:01:15 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary

    $SLSN
    Financials

    Live finance-specific insights

    See more
    • Solésence Reports Record First Quarter 2025 Financial Results

      First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025.    Recent Highlights and Accomplishments Uplisted to Nasdaq under the ticker "SLSN" supporting the Company's increased visibility with the investment communityAchieved record revenue and unit volume shipments in the first quarter 2025 "We kicked off 2025 with record revenue, fueled by strong sales across our suite of consumer products," said Jess Jankowski, President and

      5/5/25 4:01:00 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary
    • Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call

      ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (NASDAQ:SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2025 after the market close on Monday, May 5, 2025, and host a conference call and webcast on the same date. First Quarter 2025 Conference Call Details Date / Time: Monday, May 5, 2025 - 4:00 p.m. CDT, 5:00 p.m. EDT Speakers: Jess Jankowski, President & CEO, and Kevin Cureton, Chief Operating Officer Webcast Link: https://edge.media-server.com/mmc/p/q53hzimg Dial-In Link: https://register-conf.

      4/28/25 4:01:00 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary

    $SLSN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Whitmore Bradford T bought $28,093,800 worth of shares (6,689,000 units at $4.20) and sold $28,093,800 worth of shares (6,689,000 units at $4.20) (SEC Form 4)

      4 - SOLESENCE, INC. (0000883107) (Issuer)

      6/2/25 4:01:15 PM ET
      $SLSN
      Package Goods/Cosmetics
      Consumer Discretionary